Featured Stories

Fracking Boom Changing Way of Life in Pennsylvania's Northern Tier

In just a few years, the impact of hydraulic fracturing (fracking) drilling on northeastern Pennsylvania is hard to miss. Thousands of natural gas wells have been opened in that area specifically in the last five years as companies look to exploit the vast Marcellus shale formation about two miles below the ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

FDA Warns About Difficulty of Effectively Disinfecting Duodenoscopes

FDA Warns About Difficulty of Effectively Disinfecting Duodenoscopes

FDA Warns About Difficulty of Effectively Disinfecting Duodenoscopes


The Food and Drug Administration (FDA) has issued a safety communication to raise awareness that the design of ERCP endoscopes (also called duodenoscopes) may impede effective disinfection of the reusable devices.

The FDA says recent reports associate multidrug-resistant bacterial infections in patients who have undergone ERCP (endoscopic retrograde cholangiopancreatography) with reprocessed duodenoscopes, even when manufacturer-reprocessing instructions are followed correctly. Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , , , , |

FDA Never Approved Scopes Implicated in Superbug Outbreak

FDA Never Approved Scopes Implicated in Superbug Outbreak

FDA Never Approved Scopes Implicated in Superbug Outbreak


The U.S. Food and Drug Administration (FDA) never approved the model of duodenoscope implicated in the recent superbug outbreak at Ronald Reagan UCLA Medical Center, CNN reports. Between October to January, the scopes spread the superbug carbapenem-resistant Enterobacteriaceae (CRE) to seven patients, two of whom died.

According to CNN, Olympus sold their TJF-Q180V in 2010 but never sought agency approval. Karen Riley, deputy director of strategy for the FDA’s Office of External Affairs said the agency did not realize that it was never cleared for the market until late 2013 or early 2014. “Why didn’t we notice it? I don’t know,” Riley said, according to CNN. Continue reading

Posted in Legal News | Tagged , , , , , , , , |

New Generation of Weight-Loss Drugs Could Increase Risk of Colon Cancer

New Generation of Weight-Loss Drugs Increase Colon Cancer

New Generation of Weight-Loss Drugs Increase Colon Cancer


Researchers looking to explain the increased risk of colorectal cancer in individuals who have had gastric bypass surgery discovered that a new generation of weight-loss drugs may pose a similar risk.

A research team at Mt. Sinai Hospital in Toronto looked at the action of bile acids and hormones residing in the gut. These chemicals aid digestion, and some of them, including glucagon-like peptide-2 (GLP-2), also work as growth factor hormones, stimulating cell division in the intestines, Medical Daily reports. The researchers conducted an experiment using mice to explore the effects on the mice of increasing the hormone, or eliminating it. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Two Recent Court Rulings Reject Previous Court’s Interpretation of ‘Public Disclosure Bar’ in Whistleblower Lawsuits

Court Rulings Reject Court’s Interpretation

Court Rulings Reject Court’s Interpretation


Two recent court decisions may make it easier for whistleblowers to pursue a qui tam lawsuit filed under the False Claims Act (FCA). The rulings focus on the “public disclosure bar”, a procedural hurdle that dismisses a whistleblower’s case if it is “based upon the public disclosure of allegations or transactions” in specific ways, including a government “report, hearing, audit, or investigation,”; this does not apply if the whistleblower is the original source of that information.

In 1999, the U.S. Court of Appeals for the Seventh Circuit ruled that the public disclosure bar was applicable if information given to a “competent government official” was “publicly disclosed.” This decision can be problematic for whistleblowers because it allows cases to be dismissed if information was disclosed to the government but never available to the general public. Continue reading

Posted in Legal News | Tagged , , , , |

FDA Warns about Testosterone Drugs for Men

FDA Warns about Testosterone Drugs for Men

FDA Warns about Testosterone Drugs for Men


The Food and Drug Administration (FDA) has issued a warning to doctors about testosterone-boosting drugs for men. The popular treatments have not been established as safe or effective for treating common signs of aging like low libido and fatigue.

The FDA warned that the drugs may increase the risk of heart attack, stroke and other cardiovascular problems, The Associated Press (AP) reports. The agency says drug makers must clarify that their drugs are approved only to treat low testosterone levels caused by disease or injury, not normal aging. The FDA has directed manufacturers to add information to the labels about the potential risk and directed them to conduct a long-term study of the issue. Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Class Action Lawsuit over Premature Failure, Defects, and Formaldehyde in Lumber Liquidators Flooring

Lawsuit over Defects in Lumber Liquidators Flooring

Lawsuit over Defects in Lumber Liquidators Flooring


In a class action lawsuit filed in U.S. District Court in Northern California, consumers allege that their Lumber Liquidators flooring is defective and may crack, split, warp, and shrink sooner than claimed in the product’s warranty. They also allege that Lumber Liquidators flooring contains significantly high levels of the carcinogen formaldehyde.

One of the named plaintiffs, a West Virginia homeowner, had 517 square feet of flooring from Lumber Liquidators installed in her living room dining room and two hallways. According to the legal complaint, she purchased the product after reviewing samples at the store and being told by a Lumber Liquidators manager that the flooring was durable, the best product available, and sold with 30-year warranty. But within a few weeks of installation, the homeowner noticed the flooring was delaminating, warping, splitting, shrinking, scratching and deteriorating in various places. The installer made four attempts to repair the floors but Lumber Liquidators would not replace the flooring. Continue reading

Posted in Class Action Lawsuits, Defective Products, Health Concerns, Toxic Substances | Tagged , , , , |

New York’s Anti-Subrogation Law is Not Preempted by ERISA, Supreme Court Rules

NY’s Anti-Subrogation Law is Not Preempted by ERISA

NY’s Anti-Subrogation Law is Not Preempted by ERISA


A recent decision by the Supreme Court is expected to stop several insurers from attempting to cite the legal notion of subrogation, which is when insurance companies seek reimbursement for benefits paid for the insured.

Last July, the U.S. Court of Appeals for the Second Circuit ruled that New York’s anti-subrogation law is not preempted by the Employee Retirement Income Security Act (ERISA). The court ruled that the law, which prevents private health insurers from seeking reimbursement for medical benefits paid out of a tort settlement, is applicable to health insurers providing ERISA coverage. The litigation stems from a class action lawsuit originally filed in New York State Supreme Court. The case was moved to federal court when the District Court granted the defendants’ motion to dismiss for failure to state a claim based on ERISA preemption. The case was remanded to the District Court on appeal by the Court of Appeals for the Second Circuit; the court found that the plaintiffs’ claims were not subject to complete ERISA preemption. Continue reading

Posted in Legal News | Tagged , , , , |

FDA Cautions Consumers Against Buying Oxy Elite Pro

FDA Cautions Consumers Against Buying Oxy Elite Pro

FDA Cautions Consumers Against Buying Oxy Elite Pro


Consumers should think twice before purchasing weight loss supplements, particularly Oxy Elite Pro, the U.S. Food and Drug Administration (FDA) warned on Friday. According to Youth Health, a sample of Oxy Elite Pro shipped from a different country was found to have fluoxetine.

Oxy Elite Pro, like many weight loss supplements, is a type of thermogenic. This means that it tries to boost the body’s metabolism and burn fat by increasing the body’s internal heat. Continue reading

Posted in Legal News | Tagged , , , , , |

FDA Warns L’Oréal about Improper Marketing of Skin Care Products

FDA-Warns L’Oreal - Improper Marketing of Skin Care Products

FDA-Warns L’Oréal – Improper Marketing of Skin Care Products


The Food and Drug Administration (FDA) has warned cosmetic giant L’Oréal, for the second time in three years, about improper marketing of skin care products.

Cosmetic products are not subject to the same scrutiny and regulation as drugs, but cosmetics are limited in the types of claims they can make to consumers, according to Regulatory Focus (from Regulatory Affairs Professionals Society). Federal law describes cosmetics as products “intended to be rubbed, poured, sprinkled or sprayed on, introduced into or otherwise applied to the human body … for cleansing, beautifying, promoting attractiveness or altering the appearance.” Cosmetics are not intended to heal, cure or otherwise affect the body’s structure or function. But if a product is marketed for a therapeutic use, such as treating or preventing disease, it is a drug under the law. Continue reading

Posted in Consumer Fraud | Tagged , , , , |

3 Injured in Hauppauge Crash

3 Injured in Hauppauge Crash

3 Injured in Hauppauge Crash


A two-car crash involving the SUV of a Long Island fire chief in Hauppauge leaves three people injured. According to Associated Press, a car headed south on Route 111 hit an SUV belonging to the Stony Brook Fire Department chief. Parts of Routes 111 and 347 were subsequently closed. The car was driven by a man with one passenger, who suffered serious injuries and was taken to the hospital. The driver did not have any life-threatening injuries. Continue reading

Posted in Legal News | Tagged , , , , |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.